BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17623987)

  • 1. The EPO/iron marriage: counseling needed.
    Bralow S
    Nephrol News Issues; 2007 Jun; 21(7):53, 55. PubMed ID: 17623987
    [No Abstract]   [Full Text] [Related]  

  • 2. ESA therapy for anemia management: a call for civil discourse.
    McAllister CJ
    Nephrol News Issues; 2007 Jun; 21(7):49-50. PubMed ID: 17623986
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing anemia. What do we do now? Views from Canada.
    Mendelssohn DC; Muirhead N; Manns BJ
    Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous quality improvement (CQI) in rhu-Epo management: the outcome.
    Descamps C; Van Waeleghem JP; Ysebaert D
    EDTNA ERCA J; 1996; 22(3):22-6. PubMed ID: 10723328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European best practice guidelines 14-16: inadequate response to epoetin.
    Hörl WH; Jacobs C; Macdougall IC; Valderrábano F; Parrondo I; Thompson K; Carveth BG
    Nephrol Dial Transplant; 2000; 15 Suppl 4():43-50. PubMed ID: 11052148
    [No Abstract]   [Full Text] [Related]  

  • 6. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
    Fishbane S
    Blood Purif; 2007; 25(1):53-7. PubMed ID: 17170538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic guidelines for renal anemia in Japan].
    Naito M; Akiba T
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():562-5. PubMed ID: 15250369
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron overload in the erythropoietin era.
    Robbins KC
    Nephrol Nurs J; 2000 Apr; 27(2):227-31. PubMed ID: 11111550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European best practice guidelines 6-8: assessing and optimizing iron stores.
    Macdougall IC; Hörl WH; Jacobs C; Valderrábano F; Parrondo I; Thompson K; Cremers S
    Nephrol Dial Transplant; 2000; 15 Suppl 4():20-32. PubMed ID: 11052146
    [No Abstract]   [Full Text] [Related]  

  • 10. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 11. The challenges of using serum ferritin to guide i.v. iron treatment practices in patients on hemodialysis with anemia.
    Easom A
    Nephrol Nurs J; 2006; 33(5):543-51; quiz 552-3. PubMed ID: 17044438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation.
    Vaziri ND
    Am J Med; 2012 Oct; 125(10):951-2. PubMed ID: 22795817
    [No Abstract]   [Full Text] [Related]  

  • 13. European best practice guidelines 9-13: anaemia management.
    Jacobs C; Hörl WH; Macdougall IC; Valderrábano F; Parrondo I; Abraham IL; Segner A
    Nephrol Dial Transplant; 2000; 15 Suppl 4():33-42. PubMed ID: 11052147
    [No Abstract]   [Full Text] [Related]  

  • 14. Anemia in renal insufficiency.
    Santoro A
    Rev Clin Exp Hematol; 2002; Suppl 1():12-20. PubMed ID: 12735211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anemia in chronic renal failure and erythropoietin].
    Rosenlöf K
    Duodecim; 1995; 111(15):1489-95. PubMed ID: 9244705
    [No Abstract]   [Full Text] [Related]  

  • 16. European best practice guidelines 1-4: evaluating anaemia and initiating treatment.
    Valderrábano F; Hörl WH; Jacobs C; Macdougall IC; Parrondo I; Cremers S; Abraham IL
    Nephrol Dial Transplant; 2000; 15 Suppl 4():8-14. PubMed ID: 11052144
    [No Abstract]   [Full Text] [Related]  

  • 17. Updating practices in an evolving IV iron and anemia environment: practical solutions.
    Amerling R; Easom A; Juergensen P
    Nephrol Nurs J; 2007; 34(5):533-41; quiz 542-3. PubMed ID: 18041456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to optimize the concept of the variability of haemoglobin in dialysis patients].
    Kessler M
    Nephrol Ther; 2008 Dec; 4(7):547-8. PubMed ID: 18809370
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
    Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
    Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
    [No Abstract]   [Full Text] [Related]  

  • 20. Do hemodialysis patients need higher doses of erythropoietin if given intravenously rather than subcutaneously?
    McMahon LP
    Nat Clin Pract Nephrol; 2006 May; 2(5):246-7. PubMed ID: 16932434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.